Global Monkeypox Vaccine Market Growth 2025-2031

Publication ID:

LPI03257618

Publication Date:

March 4, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Monkeypox Vaccine market size is predicted to grow from US$ 7.6 million in 2025 to US$ 10.6 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Monkeypox is a viral zoonosis (a virus transmitted to humans from animals) with symptoms very similar to those seen in the past in smallpox patients, although it is clinically less severe. With the eradication of smallpox in 1980 and subsequent cessation of smallpox vaccination, monkeypox has emerged as the most important orthopoxvirus for public health. Monkeypox primarily occurs in Central and West Africa, often in proximity to tropical rainforests and has been increasingly appearing in urban areas. Animal hosts include a range of rodents and non-human primates.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淢onkeypox Vaccine Industry Forecast鈥� looks at past sales and reviews total world Monkeypox Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Monkeypox Vaccine sales for 2025 through 2031. With Monkeypox Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Monkeypox Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Monkeypox Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others
Segmentation by Application:
Aldult
Child
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Bavarian Nordic inks
Key Questions Addressed in this Report
What is the 10-year outlook for the global Monkeypox Vaccine market?
What factors are driving Monkeypox Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Monkeypox Vaccine market opportunities vary by end market size?
How does Monkeypox Vaccine break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Monkeypox Vaccine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Monkeypox Vaccine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Monkeypox Vaccine by Country/Region, 2020, 2024 & 2031
2.2 Monkeypox Vaccine Segment by Type
2.2.1 DNA
2.2.2 Non-replicating Viral Vector
2.2.3 Protein Subunit
2.2.4 RNA
2.2.5 Others
2.3 Monkeypox Vaccine Sales by Type
2.3.1 Global Monkeypox Vaccine Sales Market Share by Type (2020-2025)
2.3.2 Global Monkeypox Vaccine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Monkeypox Vaccine Sale Price by Type (2020-2025)
2.4 Monkeypox Vaccine Segment by Application
2.4.1 Aldult
2.4.2 Child
2.5 Monkeypox Vaccine Sales by Application
2.5.1 Global Monkeypox Vaccine Sale Market Share by Application (2020-2025)
2.5.2 Global Monkeypox Vaccine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Monkeypox Vaccine Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Monkeypox Vaccine Breakdown Data by Company
3.1.1 Global Monkeypox Vaccine Annual Sales by Company (2020-2025)
3.1.2 Global Monkeypox Vaccine Sales Market Share by Company (2020-2025)
3.2 Global Monkeypox Vaccine Annual Revenue by Company (2020-2025)
3.2.1 Global Monkeypox Vaccine Revenue by Company (2020-2025)
3.2.2 Global Monkeypox Vaccine Revenue Market Share by Company (2020-2025)
3.3 Global Monkeypox Vaccine Sale Price by Company
3.4 Key Manufacturers Monkeypox Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Monkeypox Vaccine Product Location Distribution
3.4.2 Players Monkeypox Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Monkeypox Vaccine by Geographic Region
4.1 World Historic Monkeypox Vaccine Market Size by Geographic Region (2020-2025)
4.1.1 Global Monkeypox Vaccine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Monkeypox Vaccine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Monkeypox Vaccine Market Size by Country/Region (2020-2025)
4.2.1 Global Monkeypox Vaccine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Monkeypox Vaccine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Monkeypox Vaccine Sales Growth
4.4 APAC Monkeypox Vaccine Sales Growth
4.5 Europe Monkeypox Vaccine Sales Growth
4.6 Middle East & Africa Monkeypox Vaccine Sales Growth
5 Americas
5.1 Americas Monkeypox Vaccine Sales by Country
5.1.1 Americas Monkeypox Vaccine Sales by Country (2020-2025)
5.1.2 Americas Monkeypox Vaccine Revenue by Country (2020-2025)
5.2 Americas Monkeypox Vaccine Sales by Type (2020-2025)
5.3 Americas Monkeypox Vaccine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Monkeypox Vaccine Sales by Region
6.1.1 APAC Monkeypox Vaccine Sales by Region (2020-2025)
6.1.2 APAC Monkeypox Vaccine Revenue by Region (2020-2025)
6.2 APAC Monkeypox Vaccine Sales by Type (2020-2025)
6.3 APAC Monkeypox Vaccine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Monkeypox Vaccine by Country
7.1.1 Europe Monkeypox Vaccine Sales by Country (2020-2025)
7.1.2 Europe Monkeypox Vaccine Revenue by Country (2020-2025)
7.2 Europe Monkeypox Vaccine Sales by Type (2020-2025)
7.3 Europe Monkeypox Vaccine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Monkeypox Vaccine by Country
8.1.1 Middle East & Africa Monkeypox Vaccine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Monkeypox Vaccine Revenue by Country (2020-2025)
8.2 Middle East & Africa Monkeypox Vaccine Sales by Type (2020-2025)
8.3 Middle East & Africa Monkeypox Vaccine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Monkeypox Vaccine
10.3 Manufacturing Process Analysis of Monkeypox Vaccine
10.4 Industry Chain Structure of Monkeypox Vaccine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Monkeypox Vaccine Distributors
11.3 Monkeypox Vaccine Customer
12 World Forecast Review for Monkeypox Vaccine by Geographic Region
12.1 Global Monkeypox Vaccine Market Size Forecast by Region
12.1.1 Global Monkeypox Vaccine Forecast by Region (2026-2031)
12.1.2 Global Monkeypox Vaccine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Monkeypox Vaccine Forecast by Type (2026-2031)
12.7 Global Monkeypox Vaccine Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Bavarian Nordic inks
13.1.1 Bavarian Nordic inks Company Information
13.1.2 Bavarian Nordic inks Monkeypox Vaccine Product Portfolios and Specifications
13.1.3 Bavarian Nordic inks Monkeypox Vaccine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Bavarian Nordic inks Main Business Overview
13.1.5 Bavarian Nordic inks Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂